AGRONOMICS LTD.LS-0000001

Research AGRONOMICS LTD.LS-0000001 (V77) on Bullrun: market cap EUR 40.09M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 40.09M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025-GBP 11.92M-GBP 32.75M-GBP 8.63Mn/a-0.03GBP 3.61Mn/aGBP 124.52M
FY2024GBP 0-GBP 10.99M-GBP 15.86Mn/a-0.01GBP 3.13Mn/aGBP 157.27M
FY2023GBP 0GBP 22.37M-GBP 23.67Mn/a0.02GBP 18.09Mn/aGBP 168.26M
FY2022GBP 440.32KGBP 8.36M-GBP 42.21Mn/a0.01GBP 31.46Mn/aGBP 143.91M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-24EUR 40.09Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

About AGRONOMICS LTD.LS-0000001

Agronomics Limited is a private equity and venture capital firm specializing in emerging growth, seed/startup, early venture, series B and growth capital investments. The firm invests in quoted and unquoted companies. It prefers to invest in the alternative proteins company with a focus on cellular agriculture, cultivated meat, technologies, nascent industry of modern foods and materials, biopharma sector and will establish a portfolio of investments in biotechnology and biopharmaceutical companies.

Related stock research

Other Financial Services stocks

Frequently asked questions

What is AGRONOMICS LTD.LS-0000001's market cap?

AGRONOMICS LTD.LS-0000001's market capitalization is EUR 40.09M.

What does AGRONOMICS LTD.LS-0000001 do?

Agronomics Limited is a private equity and venture capital firm specializing in emerging growth, seed/startup, early venture, series B and growth capital investments. The firm invests in quoted and unquoted companies. It prefers to invest in the alternative proteins company with a focus on cellular agriculture, cultivated meat, technologies, nascent industry of modern foods and materials, biopharma sector and will establish a portfolio of investments in biotechnology and biopharmaceutical companies. It also seeks to invest in clean food and biomanufacturing.